Temozolomide is a novel regional infusion agent for the treatment of advanced extremity melanoma

Tomio Ueno, Sae Hee Ko, Elizabeth Grubbs, Scott K. Pruitt, Henry S. Friedman, Douglas Tyler

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Regional infusion therapy with melphalan (LPAM) is an accepted treatment for advanced extremity melanoma. However, much room exists for improving the therapeutic index of this type of therapy. Isolated limb infusion (ILI) with temozolomide (TMZ), a novel methylating agent, was performed using a nude rat bearing human melanoma xenograft. Additional rats were treated systemically with TMZ, or regionally with LPAM or 10% dimethyl sulfoxide (DMSO; control) using ILI. Rats that received systemic TMZ showed a poor tumor response and no tumor regression. In contrast, intra-arterial TMZ demonstrated a prolongation of tumor growth delay in a dose-responsive manner. In comparison with LPAM of equitoxic dose, TMZ provided both longer tumor growth delay and a greater number of tumor regressions. These data suggest that ILI with TMZ is an effective treatment for advanced extremity melanoma and may be better than LPAM in this setting.

Original languageEnglish (US)
Pages (from-to)532-537
Number of pages6
JournalAmerican Journal of Surgery
Volume188
Issue number5
DOIs
StatePublished - Nov 2004
Externally publishedYes

Fingerprint

temozolomide
Melanoma
Extremities
Neoplasms
Dimethyl Sulfoxide
Nude Rats
Melphalan
Growth
Heterografts
Therapeutics

Keywords

  • Isolated limb infusion
  • Isolated limb perfusion
  • Melanoma
  • Melphalan
  • Regional chemotherapy
  • Temozolomide

ASJC Scopus subject areas

  • Surgery

Cite this

Temozolomide is a novel regional infusion agent for the treatment of advanced extremity melanoma. / Ueno, Tomio; Ko, Sae Hee; Grubbs, Elizabeth; Pruitt, Scott K.; Friedman, Henry S.; Tyler, Douglas.

In: American Journal of Surgery, Vol. 188, No. 5, 11.2004, p. 532-537.

Research output: Contribution to journalArticle

Ueno, Tomio ; Ko, Sae Hee ; Grubbs, Elizabeth ; Pruitt, Scott K. ; Friedman, Henry S. ; Tyler, Douglas. / Temozolomide is a novel regional infusion agent for the treatment of advanced extremity melanoma. In: American Journal of Surgery. 2004 ; Vol. 188, No. 5. pp. 532-537.
@article{f978a7739ba14fe69af9b38f76b3623c,
title = "Temozolomide is a novel regional infusion agent for the treatment of advanced extremity melanoma",
abstract = "Regional infusion therapy with melphalan (LPAM) is an accepted treatment for advanced extremity melanoma. However, much room exists for improving the therapeutic index of this type of therapy. Isolated limb infusion (ILI) with temozolomide (TMZ), a novel methylating agent, was performed using a nude rat bearing human melanoma xenograft. Additional rats were treated systemically with TMZ, or regionally with LPAM or 10{\%} dimethyl sulfoxide (DMSO; control) using ILI. Rats that received systemic TMZ showed a poor tumor response and no tumor regression. In contrast, intra-arterial TMZ demonstrated a prolongation of tumor growth delay in a dose-responsive manner. In comparison with LPAM of equitoxic dose, TMZ provided both longer tumor growth delay and a greater number of tumor regressions. These data suggest that ILI with TMZ is an effective treatment for advanced extremity melanoma and may be better than LPAM in this setting.",
keywords = "Isolated limb infusion, Isolated limb perfusion, Melanoma, Melphalan, Regional chemotherapy, Temozolomide",
author = "Tomio Ueno and Ko, {Sae Hee} and Elizabeth Grubbs and Pruitt, {Scott K.} and Friedman, {Henry S.} and Douglas Tyler",
year = "2004",
month = "11",
doi = "10.1016/j.amjsurg.2004.07.014",
language = "English (US)",
volume = "188",
pages = "532--537",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Temozolomide is a novel regional infusion agent for the treatment of advanced extremity melanoma

AU - Ueno, Tomio

AU - Ko, Sae Hee

AU - Grubbs, Elizabeth

AU - Pruitt, Scott K.

AU - Friedman, Henry S.

AU - Tyler, Douglas

PY - 2004/11

Y1 - 2004/11

N2 - Regional infusion therapy with melphalan (LPAM) is an accepted treatment for advanced extremity melanoma. However, much room exists for improving the therapeutic index of this type of therapy. Isolated limb infusion (ILI) with temozolomide (TMZ), a novel methylating agent, was performed using a nude rat bearing human melanoma xenograft. Additional rats were treated systemically with TMZ, or regionally with LPAM or 10% dimethyl sulfoxide (DMSO; control) using ILI. Rats that received systemic TMZ showed a poor tumor response and no tumor regression. In contrast, intra-arterial TMZ demonstrated a prolongation of tumor growth delay in a dose-responsive manner. In comparison with LPAM of equitoxic dose, TMZ provided both longer tumor growth delay and a greater number of tumor regressions. These data suggest that ILI with TMZ is an effective treatment for advanced extremity melanoma and may be better than LPAM in this setting.

AB - Regional infusion therapy with melphalan (LPAM) is an accepted treatment for advanced extremity melanoma. However, much room exists for improving the therapeutic index of this type of therapy. Isolated limb infusion (ILI) with temozolomide (TMZ), a novel methylating agent, was performed using a nude rat bearing human melanoma xenograft. Additional rats were treated systemically with TMZ, or regionally with LPAM or 10% dimethyl sulfoxide (DMSO; control) using ILI. Rats that received systemic TMZ showed a poor tumor response and no tumor regression. In contrast, intra-arterial TMZ demonstrated a prolongation of tumor growth delay in a dose-responsive manner. In comparison with LPAM of equitoxic dose, TMZ provided both longer tumor growth delay and a greater number of tumor regressions. These data suggest that ILI with TMZ is an effective treatment for advanced extremity melanoma and may be better than LPAM in this setting.

KW - Isolated limb infusion

KW - Isolated limb perfusion

KW - Melanoma

KW - Melphalan

KW - Regional chemotherapy

KW - Temozolomide

UR - http://www.scopus.com/inward/record.url?scp=8544245666&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8544245666&partnerID=8YFLogxK

U2 - 10.1016/j.amjsurg.2004.07.014

DO - 10.1016/j.amjsurg.2004.07.014

M3 - Article

C2 - 15546565

AN - SCOPUS:8544245666

VL - 188

SP - 532

EP - 537

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 5

ER -